NVCHI
FLGT icon

New Vernon Capital Holdings II’s Fulgent Genetics FLGT Stock Holding History

New Vernon Capital Holdings II’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,619
Closed -$144K – 78
2023
Q1 		$144K Buy
4,619
+56
+1% +$1.8K 0.11% 73
2022
Q4 		$136K Buy
4,563
+2,920
+178% +$104K 0.11% 72
2022
Q3 		$63K Sell
1,643
-174
-10% -$8.72K 0.07% 61
2022
Q2 		$99K Buy
+1,817
New +$99.9K 0.08% 51

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

New Vernon Capital Holdings II's FLGT Position: Q2 2023 in Review

New Vernon Capital Holdings II sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 4,619 shares — an estimated $144K sold.

New Vernon Capital Holdings II first reported a position in FLGT in Q2 2022 and held it in 4 quarters. The position peaked at $144K in Q1 2023. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • New Vernon Capital Holdings II reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 4,619 Fulgent Genetics shares in Q2 2023, an estimated $144K.
  • New Vernon Capital Holdings II first reported a position in Fulgent Genetics in Q2 2022 and held it in 4 quarters.
  • New Vernon Capital Holdings II's Fulgent Genetics position peaked at $144K in Q1 2023.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on New Vernon Capital Holdings II's 13F filing for Q2 2023, filed 14 Aug 2023.